Dr. Phelan is a molecular geneticist. She has published more than 60 primary research reports in the areas of breast and ovarian cancer and maintains active collaborations with investigators throughout the world through her participation in the Ovarian Cancer Association Consortium. Currently, she is funded to investigate genetic susceptibility to ovarian cancer in both the genome-wide association study (GWAS) and candidate gene/pathway approach involving mitochondria-related apoptosis, epithelial-mesenchymal transition (EMT) and oxidative phosphorylation pathways. Additionally, Dr. Phelan has research interests in high-risk breast and ovarian cancer genes, reflected in the list of publications, below. Dr. Phelan has a research interest in cancer health disparities and is co-leader of the Research Training and Education Core (RTEC) of the Center for Equal Health: Community Partnerships in Research, Education and Training. The Center for Equal Health focuses on reducing cancer-related disparities among Florida’s minority and underserved populations.